The Role of Liquid Biopsies in Early Cancer Detection and Monitoring
Abstract
Liquid biopsies have emerged as a transformative tool in oncology, offering a minimally invasive method for early cancer detection and real-time monitoring of disease progression. This literature review explores the technological advancements and clinical applications of liquid biopsies, focusing on their role in detecting circulating tumor cells (CTCs), cell-free DNA (cfDNA), and other biomarkers. We examine the efficacy of liquid biopsies in early cancer screening, their potential for monitoring treatment response, and their ability to detect recurrence and metastasis. Despite the promising applications, challenges such as technical limitations, biological variability, and cost-effectiveness must be addressed to fully integrate liquid biopsies into routine clinical practice. The future of liquid biopsies looks promising, with emerging trends in multi-omic approaches and artificial intelligence paving the way for more personalized and effective cancer care. This review included 34 peer-reviewed studies identified through a systematic PRISMA-guided search across four databases.
Keywords: Liquid Biopsies, Early Cancer Detection, Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Cancer Monitoring, Multi-omics, Artificial Intelligence in Cancer Diagnostics, Real-time Monitoring.
Full Text:
PDFReferences
Bankó, P., Lee, S.Y., Nagygyörgy, V., Zrínyi, M., Chae, C.H., Cho, D.H., and Telekes, A., 2019, Technologies for circulating tumor cell separation from whole blood, Journal of Hematology & Oncology, 12(1), 48. CrossRef
Bettegowda, C., Sausen, M., Leary, R.J., Kinde, I., Wang, Y., Agrawal, N., et al., 2014, Detection of circulating tumor DNA in early- and late-stage human malignancies, Science Translational Medicine, 6(224), 224ra24. CrossRef
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D.C., 2019, Genome-wide cell-free DNA fragmentation in patients with cancer, Nature, 570(7761), 385–389. CrossRef
Dao, J., Conway, P.J., Subramani, B., Meyyappan, D., Russell, S., and Mahadevan, D., 2023, Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation, International Journal of Molecular Sciences, 24(17), 13219. CrossRef
Deveson, I.W., Gong, B., Lai, K., LoCoco, J.S., Richmond, T.A., Schageman, J., et al., 2021, Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology, Nature Biotechnology, 39, 1115–1128. CrossRef
El Achi, H., Khoury, J.D., and Loghavi, S., 2019, Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer, Current Hematologic Malignancy Reports, 14, 358–367. CrossRef
Goodman, C.R., Seagle, B.L., Friedl, T.W.P., Rack, B., Lato, K., and Fink, V., 2018, Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer, JAMA oncology, 4(8), e180163. CrossRef
Graves, P.R., and Haystead, T.A., 2002, Molecular biologist’s guide to proteomics, Microbiology and Molecular Biology Reviews: MMBR, 66(1), 39–63. CrossRef
Hasin, Y., Seldin, M., and Lusis, A., 2017, Multi-omics approaches to disease, Genome Biology, 18, 83. CrossRef
Heitzer, E., Haque, I.S., Roberts, C.E.S., and Speicher, M.R., 2019, Current and future perspectives of liquid biopsies in genomicsdriven oncology, Nature Reviews Genetics, 20, 71–88. CrossRef
Horgan, R.P., and Kenny, L.C., 2011, ‘Omic’ technologies: genomics, transcriptomics, proteomics and metabolomics, The Obstetrician & Gynaecologist, 13(3), 189–195. CrossRef
Ignatiadis, M., and Reinholz, M., 2011, Minimal residual disease and circulating tumor cells in breast cancer, Breast Cancer Research, 13, 222. CrossRef
Jensen, T.J., Goodman, A.M., Kato, S., Ellison, C.K., Daniels, G.A., Kim, L., et al., 2019, Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients, Molecular Cancer Therapeutics, 18(2), 448–458. CrossRef
Ju, S., Chen, C., Zhang, J., Xu, L., Zhang, X., Li, Z., et al., 2022, Detection of circulating tumor cells: opportunities and challenges, Biomarker Research, 10, 58. CrossRef
Kalluri, R., and LeBleu, V.S., 2020, The biology, function, and biomedical applications of exosomes, Science, 367(6478), eaau6977. CrossRef
Kumar, V., Garg, V.K., Kumar, S., and Biswas, J.K., 2022, Omics for Environmental Engineering and Microbiology Systems. In CRC Press eBooks. CrossRef
Lone, S.N., Nisar, S., Masoodi, T., Singh, M., Rizwan, A., Hashem, S., et al., 2022, Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments, Molecular cancer, 21, 79. CrossRef
Milbury, C.A., Li, J., and Makrigiorgos, G.M., 2009, PCR-based methods for the enrichment of minority alleles and mutations, Clinical Chemistry, 55(4), 632–640. CrossRef
Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., et al., 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences of the United States of America, 105(30), 10513–10518. CrossRef
Nair, N., Camacho-Vanegas, O., Rykunov, D., Dashkoff, M., Camacho, S.C., Schumacher, C.A., et al., 2016, Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study, PLoS Medicine, 13(12), e1002206. CrossRef
Ogt. (n.d.). Liquid biopsy: advantages, limitations & outlook | OGT blog. OGT. https://www.ogt.com/about-us/ogt-blog/liquid-biopsy-advantages-limitations-and-outlook/
Pierga, J.Y., Petit, T., Lévy, C., Ferrero, J.M., Campone, M., Gligorov, J., et al., 2015, Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data, Clinical Cancer Research, 21(6), 1298–1304. CrossRef
Robertson, E.G., and Baxter, G., 2011, Tumour seeding following percutaneous needle biopsy: the real story!, Clinical Radiology, 66(11), 1007–1014. CrossRef
Shen, H., Jin, Y., Zhao, H., Wu, M., Zhang, K., Wei, Z., et al., 2022, Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer, BMC Medicine, 20, 480. CrossRef
Siravegna, G., Marsoni, S., Siena, S., and Bardelli, A., 2017, Integrating liquid biopsies into the management of cancer, Nature Reviews Clinical Oncology, 14, 531–548. CrossRef
Souza, V.G.P., Forder, A., Brockley, L.J., Pewarchuk, M.E., Telkar, N., de Araújo, R.P., et al., 2023, Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis, International Journal of Molecular Sciences, 24(10), 8894. CrossRef
Staff, C.T., 2021, How Liquid Biopsies Can Complement Tissue Biopsies-American Association for Cancer Research (AACR), American Association for Cancer Research (AACR). https://www.aacr.org/blog/2021/03/19/how-liquid-biopsies-can-complement-tissue-biopsies/
Tao, X.Y., Li, Q.Q., and Zeng, Y., 2024, Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring, Molecular Cancer, 23, 145. CrossRef
Théry, C., Witwer, K.W., Aikawa, E., Alcaraz, M.J., Anderson, J.D., Andriantsitohaina, R., et al., 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, Journal of Extracellular Vesicles, 7(1), 1535750. CrossRef
Trapp, E., Janni, W., Schindlbeck, C., Jückstock, J., Andergassen, U., de Gregorio, A., et al., 2019, Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis, Journal of the National Cancer Institute, 111(4), 380–387. CrossRef
Tsui, D.W.Y., Blumenthal, G.M., Philip, R., Barrett, J.C., Montagut, C., Bramlett, K., et al., 2020, Development, Validation, and Regulatory Considerations for a Liquid Biopsy Test, Clinical chemistry, 66(3), 408–414. CrossRef
Vidlarova, M., Rehulkova, A., Stejskal, P., Prokopova, A., Slavik, H., Hajduch, M., and Srovnal, J., 2023, Recent Advances in Methods for Circulating Tumor Cell Detection, International Journal of Molecular Sciences, 24(4), 3902. CrossRef
Wishart D.S., 2019, Metabolomics for Investigating Physiological and Pathophysiological Processes, Physiological Reviews, 99(4), 1819–1875. CrossRef
Zhu, W., Love, K., Gray, S.W., and Raz, D.J., 2023, Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions, Clinical Lung Cancer, 24(3), 209–217. CrossRef
DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev16iss1pp67-78
Copyright (c) 2026 Indonesian Journal of Cancer Chemoprevention
Indexed by:
Indonesian Society for Cancer Chemoprevention
